Document is current

Any future updates will be listed below

Resmetirom, the first FDA-approved drug for MASH: From drug discovery and action mechanisms to clinical trials

Crossref DOI link: https://doi.org/10.1007/s12272-025-01574-w

Published Online: 2025-10-30

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark